Literature DB >> 3135033

Idiosyncratic reaction resembling toxic epidermal necrolysis caused by chloroquine and maloprim.

P A Phillips-Howard1, J Warwick Buckler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3135033      PMCID： PMC2545992          DOI： 10.1136/bmj.296.6636.1605

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  [Erythroderma exfoliativum after chloroquine treatment].

Authors:  M L BIILMANN-PETERSEN
Journal:  Ugeskr Laeger       Date:  1959-04-09

2.  Toxic Epidermal Necrolysis.

Authors:  S G Browne; E Ridge
Journal:  Br Med J       Date:  1961-02-25

3.  Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.

Authors:  U Hellgren; L Rombo; B Berg; J Carlson; B E Wiholm
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-08

4.  Toxic epidermal necrolysis. Unmuddying the waters.

Authors:  S M Goldstein; B W Wintroub; P M Elias; K D Wuepper
Journal:  Arch Dermatol       Date:  1987-09

5.  Severe dapsone syndrome due to weekly maloprim.

Authors:  M L Grayson; A P Yung; R R Doherty
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

6.  Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

Authors:  K D Miller; H O Lobel; R F Satriale; J N Kuritsky; R Stern; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1986-05       Impact factor: 2.345
  6 in total
  3 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors:  D Stürchler; M L Mittelholzer; L Kerr
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

3.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.